
Canada - Toronto Stock Exchange - TSX:CAN - CA13585U1093 - Common Stock
The current stock price of CAN.CA is 0.19 CAD. In the past year, price decreased by -17.39%.
ChartMill assigns a technical rating of 3 / 10 to CAN.CA. When comparing the yearly performance of all stocks, CAN.CA is a bad performer in the overall market: 84.59% of all stocks are doing better.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | N/A | ||
| ROE | N/A | ||
| Debt/Equity | N/A |
Cardiome Pharma Corporation is a biopharmaceutical company which discovers, develops and commercializes new therapies that improve the health of patients around the world.
CANADIAN GOLD RESOURCES LTD
6190 Agronomy Road
Vancouver BC V6T 1Z3
CEO: Douglas G. Janzen
Phone: +1 604 677-6905
Cardiome Pharma Corporation is a biopharmaceutical company which discovers, develops and commercializes new therapies that improve the health of patients around the world.
The current stock price of CAN.CA is 0.19 CAD.
CAN.CA does not pay a dividend.
CAN.CA has a ChartMill Technical rating of 3 out of 10.You can find more details on the Technical Analysis and Fundamental Analysis tabs.
This depends on your investment goals. Check the Technical and Fundamental Analysis tabs for insights on CAN.CA.